France Pharmaceutical Intermediates Market Outlook

france has one of the most robust and developed systems of healthcare in europe, and the pharmaceuticals market has grown significantly since 2000. the pharmaceutical industry in france has a large number of players, and is a major provider of drugs and products to the rest of europe. in 2017, france’s pharmaceuticals market was valued at eur 29.37 billion, and is estimated to grow at a compound annual growth rate (cagr) of 3.2% between 2018 to 2032. the demand for france's pharmaceutical intermediates has increased in the past few years as well, with most of the increase driven by a shift towards generic drugs and the need for cost efficiency in france’s pharmaceuticals market. the increased use of generics has pushed up the overall market share of pharmaceutical intermediates, which is expected to grow at a cagr of 4.4% from 2018 to 2032. the usage of pharmaceutical intermediates in france has also been driven by the increased emphasis given to the development of novel medications and advanced therapies. the french government has been providing ample financial support for such research and development, which has allowed pharmaceutical intermediates to gain popularity in france. additionally, the strengthening of france’s drug regulation protocols has also resulted in increasing demand for such ingredients. driven by such positive developments, the france pharmaceutical intermediates market is estimated to be worth eur 5.74 billion by 2032, indicating a steady growth rate over the course of the next decade. as a result, numerous foreign companies have set up their bases in france and the number of suppliers of pharmaceutical intermediates in the country has grown significantly over the years. to conclude, the demand for france’s pharmaceutical intermediates is visibly increasing, and is expected to continue to grow in value over the next decade. the increased focus on drug development and generic drugs has resulted ina boom in the pharmaceutical intermediates market especially in france, and the country is expected to provide ample business opportunities for foreign companies looking to enter the european market.